duloxetine ratiopharm 60 mg enterokapseli, kova
ratiopharm gmbh - duloxetini hydrochloridum - enterokapseli, kova - 60 mg - duloksetiini
duloxetine sandoz 30 mg enterokapseli, kova
sandoz a/s sandoz a/s - duloxetini hydrochloridum - enterokapseli, kova - 30 mg - duloksetiini
duloxetine sandoz 60 mg enterokapseli, kova
sandoz a/s sandoz a/s - duloxetini hydrochloridum - enterokapseli, kova - 60 mg - duloksetiini
thiopental panpharma 1 g injektiokuiva-aine, liuosta varten
panpharma - thiopental sodium - injektiokuiva-aine, liuosta varten - 1 g - tiopentaali
thiopental panpharma 0.5 g injektiokuiva-aine, liuosta varten
panpharma - thiopental sodium - injektiokuiva-aine, liuosta varten - 0.5 g - tiopentaali
tibsovo
les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastiset aineet - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.
tenofovir disoproxil teva 245 mg tabletti, kalvopäällysteinen
teva b.v. - tenofoviri disoproxili phosphas - tabletti, kalvopäällysteinen - 245 mg - tenofoviiridisoproksiili
citanest dental octapressin 30 mg/ml + 0,54 mikrog/ml injektioneste, liuos
dentsply detrey gmbh - felypressin, prilocaine hydrochloride - injektioneste, liuos - 30 mg/ml + 0,54 mikrog/ml - prilokaiini